P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP Theodoros Vassilakopoulos , B Ferhanoglu , Na Horowitz , J Apostolidis , Z Mellios , Alexia Piperidou , L Kaynar , M Zektser , A Giotasmater , Dei Hospital , Msida Malta , A Symeonidis , C Kalpadakis , A Agathocleous , Om Akay , A Sayyed , Sc Atalar , E Katodritou , T Leonidopoulou , Sg Papageorgiou , T. Tadmor , O Gutwein , S Karakatsanis , C Ganzel , G. Karianakis , G. Y. Isenberg , G Gainaru , E. Vrakidou , M Palassopoulou , M Ozgur , Marina Siakantaris , S Paydas , P Tsirigotis , M Tsirogianni , E Hatzimichael , Tf Tugular , Jv Assimakopoulos , L Ligdi , A Liaskas , Maria Aikaterini Lefaki , P Labropoulou , A Kopsaftopoulou , E Verrou , M Kanellias , P Zikos , A Koumarianou , A Gafter-Gvili , M Bouzani , Mk Angelopoulou , T Karmiris , R Gurion HemaSphere(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper